NON-INSULIN DRUGS IN DIABETES MELLITUS TYPE 1 (METFORMINE, IDPP-4, PRAMLINTIDA, AGLP-1, ISGLT-2)
There are approximately 25 million patients with type 1 diabetes mellitus (DM1) in the world, a figure that would triple in 2050. Although the optimum is to reach A1c levels <7% to avoid and / or slow down the onset / evolution of chronic complications, only 30% of patients achieve this. Furtherm...
Main Author: | |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Sello Editorial Lugones
2020-07-01
|
Series: | Revista de la Sociedad Argentina de Diabetes |
Subjects: | |
Online Access: | https://www.revistasad.com/index.php/diabetes/article/view/230 |